S2 Ep8: OncView™ Podcast: NCCN Guideline Updates in HR+ Breast Cancer

Update: 2021-08-20

Description

As part of its OncView™ video series, CancerNetwork® spoke with Lee Schwartzberg, MD, FACP, of the West Cancer Center and Research Institute in Germantown, Tennessee, about updates to the National Comprehensive Cancer Network (NCCN) guidelines regarding hormone receptor (HR)–positive breast cancer.

In the video series, Lee Schwartzberg, MD, FACP, discussed the following:

· Extended Adjuvant Therapy for HR+ Breast Cancer

· Molecular Biomarkers for HR+ Breast Cancer

· Role of Genomic Testing in HR Positive Breast Cancer

· Appropriateness for Genomic Testing in HR+ Breast Cancer

· Integration of Genomic Testing into NCCN Guidelines

· Current Recommendations for Genomic Testing in HR+ Breast Cancer

· Treatment Limitations in HR+ Breast Cancer

To watch more videos in CancerNetwork®’s OncView™ series, visit cancernetwork.com/oncview.

Don’t forget to subscribe to the “Oncology Peer Review On-The-Go” podcast on Apple Podcasts, Spotify or anywhere podcasts are available.

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

$S2 Ep26: Between the Lines Podcast: Tazemetostat in Relapsed/Refractory Follicular Lymphoma$

S2 Ep26: Between the Lines Podcast: Tazemetostat in Relapsed/Refractory Follicular Lymphoma

2022-11-0321:10

$S2 Ep25: Between the Lines™ Podcast: Updates in Use of Proteasome Inhibitors for Relapsed/Refractory Multiple Myeloma$

S2 Ep25: Between the Lines™ Podcast: Updates in Use of Proteasome Inhibitors for Relapsed/Refractory Multiple Myeloma

2022-05-2022:24

S2 Ep24: OncView™ Podcast: Advances in Systemic Therapy of Differentiated Thyroid Cancer

2022-05-0634:36

S2 Ep23: OncView™ Podcast: Safety and Efficacy of Available Treatment Options and Considerations for Patient Management in Metastatic RCC

2022-04-2930:07

S2 Ep22: Between the Lines™ Podcast: Mobocertinib Use in Platinum-Pretreated Patients With EGFR Exon 20 Insertion–Positive mNSCLC

2022-04-2727:37

S2 Ep21: OncView™ Podcast: EGFR Exon 20 Insertion as Therapeutic Target in NSCLC

2022-04-0821:01

S2 Ep20: Between the Lines™ Podcast: ctDNA as a Biomarker of Progression in Colorectal Cancer

2022-04-0525:24

S2 Ep19: OncView™ Podcast: Immunotherapy Response Monitoring in Melanoma

2022-04-0243:51

S2 Ep18: OncView™ Podcast: Immunotherapy Response Monitoring in Lung Cancer

2022-03-3018:12

S2 Ep17: Between the Lines™ Podcast: Incorporating Real-World Evidence into Clinical Decisions in NSCLC

2022-01-1441:45

S2 Ep16: Future Directions in Small Cell Lung Cancer Treatment

2021-12-2207:44

S2 Ep15: Practical Considerations for Small Cell Lung Cancer Therapeutic Options

2021-12-1613:21

$S2 Ep14: Treatment Options for Relapsed/Refractory Small Cell Lung Cancer$

S2 Ep14: Treatment Options for Relapsed/Refractory Small Cell Lung Cancer

2021-12-0213:38

S2 Ep13: First-Line Therapeutic Options in Small Cell Lung Cancer

2021-11-0110:08

S2 Ep12: OncView™ Podcast: Connie Batlevi, MD, PhD on R/R Follicular Lymphoma Therapy Updates

2021-10-2925:10

S2 Ep11: Between the Lines: PET/CT-Guided Postprostatectomy Salvage Radiotherapy for Prostate Cancer

2021-10-1936:20

S2 Ep10: Two Experts Review Important R/R DLBCL Treatment Decisions and Data

2021-08-3018:13

$S2 Ep9: OncView™ Podcast: Updates in Therapies of Relapsed/Refractory Follicular Lymphoma$

S2 Ep9: OncView™ Podcast: Updates in Therapies of Relapsed/Refractory Follicular Lymphoma

2021-08-2520:09

S2 Ep8: OncView™ Podcast: NCCN Guideline Updates in HR+ Breast Cancer

2021-08-2023:22

S2 Ep7: Kami Maddocks, MD, on Rituximab Rechallenging and Second-Line Therapies for R/R DLBCL

2021-07-3014:25

00:00

S2 Ep8: OncView™ Podcast: NCCN Guideline Updates in HR+ Breast Cancer

#box-pro-ellipsis-173697541459988{-webkit-line-clamp:2;}S2 Ep8: OncView™ Podcast: NCCN Guideline Updates in HR+ Breast Cancer

S2 Ep8: OncView™ Podcast: NCCN Guideline Updates in HR+ Breast Cancer

CancerNetwork

S2 Ep8: OncView™ Podcast: NCCN Guideline Updates in HR+ Breast Cancer